MicroRNA-199b-5p Impairs Cancer Stem Cells through Negative Regulation of HES1 in Medulloblastoma
By Livia Garzia, Immacolata Andolfo, Emilio Cusanelli, Natascia Marino, Giuseppe Petrosino, Daniela De Martino, Veronica Esposito, Aldo Galeone, Luigi Navas, Silvia Esposito, Sara Gargiulo, Sarah Fattet, Vittoria Donofrio, Giuseppe Cinalli, Arturo Brunetti, Luigi Del Vecchio, Paul A. Northcott, Olivier Delattre, Michael D. Taylor, Achille Iolascon and Massimo Zollo
(1995). A cytomorphological scheme of differentiating neuronal phenotypes in cerebellar medulloblastomas based on immunolocalization of class III beta-tubulin isotype (beta III) and proliferating cell nuclear antigen (PCNA)/cyclin.
(2001). Activated Notch2 signaling inhibits differentiation of cerebellar granule neuron precursors by maintaining proliferation.
(2008). Aggressive infantile embryonal tumors.
(2008). An embryonic stem cell-like gene expression signature in poorly differentiated aggressive human tumors.
(1997). Animal model of human medulloblastoma: clinical, magnetic resonance imaging, and histopathological findings after intra-cisternal injection of MHH-MED-1 cells into nude rats.
(2008). Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival.
(2004). Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas.
(2005). Cancer biology: summing up cancer stem cells.
(2004). Cancer stem cells in nervous system tumors.
(2008). Cancer stem cells: the lessons from pre-cancerous stem cells.
(2006). Comprehensive analysis of microRNA expression patterns in hepatocellular carcinoma and non-tumorous tissues.
(2007). Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma.
(2002). Cytogenetics and molecular genetics of bladder cancer: a personal view.
(2007). Daoy medulloblastoma cells that express CD133 are radioresistant relative to CD1332 cells, and the CD133+ sector is enlarged by hypoxia.
(2000). Expression of the neurotrophin receptor p75NTR in medulloblastomas is correlated with distinct histological and clinical features: evidence for a medulloblastoma subtype derived from the external granule cell layer.
(2001). Expression profiling of medulloblastoma: PDGFRA and the RAS/MAPK pathway as therapeutic targets for metastatic disease.
(2005). Extensive modulation of a set of microRNAs in primary glioblastoma.
(2002). Frequent deletions and down-regulation of micro-
(2006). Glioma stem cells promote radioresistance by preferential activation of the DNA damage response.
(2004). Hes genes regulate size, shape and histogenesis of the nervous system by control of the timing of neural stem cell differentiation.
(2006). High-dose chemotherapy in children with newly-diagnosed medulloblastoma.
(2004). Identification of human brain tumour initiating cells.
(1996). Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo.
(2006). Loss of cyclin D1 impairs cerebellar development and suppresses medulloblastoma formation.
(2008). Medulloblastoma can be initiated by deletion of Patched in lineage-restricted progenitors or stem cells.
(2008). Medulloblastoma stem cells.
(2005). Medulloblastoma: developmental mechanisms out of control.
(2007). MicroRNA-29 family reverts aberrant methylation in lung cancer by targeting DNA methyltransferases 3A and 3B.
(2006). MicroRNAs as oncogenes.
(2004). MicroRNAs: genomics, biogenesis, mechanism, and function.
(1980). Microtubule-associated proteins: a monoclonal antibody to MAP2 binds to differentiated neurons.
(2006). Notch pathway inhibition depletes stem-like cells and blocks engraftment in embryonal brain tumors.
(2004). Notch1 and notch2 have opposite effects on embryonal brain tumor growth.
(2007). Outcome of children with posterior fossa medulloblastoma: a single institution experience over the decade 1994–2003.
(2003). PDGFRB is overexpressed in metastatic medulloblastoma.
(2004). Persistence of a small subpopulation of cancer stem-like cells in the C6 glioma cell line.
(1994). Persistent expression of helix-loop-helix factor HES-1 prevents mammalian neural differentiation in the central nervous system.
(2004). Phenylbutyrate and phenylacetate induce differentiation and inhibit proliferation of human medulloblastoma cells.
(2005). Radiationinduced cerebellar glioblastoma at the site of a treated medulloblastoma: case report.
(2003). Reduced accumulation of specific microRNAs in colorectal neoplasia.
(1995). Results of radiosurgery in the management of recurrent and residual medulloblastoma.
(2006). RNAi-mediated gene silencing in non-human primates.
(1995). Targeted disruption of mammalian hairy and Enhancer of split homolog-1 (HES-1) leads to up-regulation of neural helix-loop-helix factors, premature neurogenesis, and severe neural tube defects.
(2000). The bHLH gene hes1 as a repressor of the neuronal commitment of CNS stem cells.
(2004). The microRNA Registry.
(2008). The origins of medulloblastoma subtypes.
(2007). The role of site accessibility in microRNA target recognition.
(2008). The Smo/Smo model: hedgehog-induced medulloblastoma with 90% incidence and leptomeningeal spread.
(2004). The SmoA1 mouse model reveals that notch signaling is critical for the growth and survival of sonic hedgehog-induced medulloblastomas.
(2005). Treatment of medulloblastoma with postoperative chemotherapy alone: an SFOP prospective trial in young children.
(2007). Tumour invasion and metastasis initiated by microRNA-10b in breast cancer.
(2006). Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.